Paroxetine: Restore Emotional Balance with Effective SSRI Therapy
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.47 | $44.18 (0%) | 🛒 Add to cart |
| 60 | $1.15 | $88.36 $69.28 (22%) | 🛒 Add to cart |
| 90 | $1.06 | $132.54 $95.39 (28%) | 🛒 Add to cart |
| 120 | $1.00 | $176.72 $120.49 (32%) | 🛒 Add to cart |
| 180 | $0.94 | $265.08 $169.69 (36%) | 🛒 Add to cart |
| 270 | $0.91 | $397.61 $247.00 (38%) | 🛒 Add to cart |
| 360 | $0.90
Best per pill | $530.15 $322.31 (39%) | 🛒 Add to cart |
Synonyms
| |||
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) widely prescribed for the management of major depressive disorder, anxiety disorders, and related conditions. As a potent and well-studied agent in its class, it functions by increasing serotonin levels in the brain, which helps improve mood, reduce anxiety, and enhance overall emotional stability. Clinicians value paroxetine for its efficacy, established safety profile, and versatility across multiple psychiatric indications, making it a cornerstone in modern psychopharmacology.
Features
- Active ingredient: Paroxetine hydrochloride
- Available formulations: immediate-release tablets, controlled-release tablets, oral suspension
- Standard strengths: 10 mg, 20 mg, 30 mg, 40 mg tablets; 12.5 mg, 25 mg, 37.5 mg controlled-release
- Half-life: approximately 21 hours (immediate-release)
- Bioavailability: Completely absorbed after oral administration
- Metabolism: Hepatic, primarily via CYP2D6
- Excretion: Renal (64%) and fecal (36%)
Benefits
- Effectively alleviates symptoms of major depressive disorder, including low mood, anhedonia, and fatigue.
- Reduces the frequency and severity of panic attacks, social anxiety, and generalized anxiety disorder.
- Helps manage symptoms of obsessive-compulsive disorder (OCD) by diminishing intrusive thoughts and compulsive behaviors.
- Approved for post-traumatic stress disorder (PTSD), aiding in the reduction of hyperarousal and avoidance symptoms.
- May provide relief for vasomotor symptoms associated with menopause, though this is an off-label use.
- Contributes to long-term emotional stability with consistent use under medical supervision.
Common use
Paroxetine is indicated for the treatment of major depressive disorder (MDD) in adults. It is also FDA-approved for panic disorder, social anxiety disorder (SAD), generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD). Off-label uses may include premenstrual dysphoric disorder (PMDD), vasomotor symptoms of menopause, and certain chronic pain conditions, though these should only be pursued under specialist guidance.
Dosage and direction
Dosage must be individualized based on diagnosis, patient response, and tolerability. For major depressive disorder, the usual starting dose is 20 mg once daily, preferably in the morning. Dose adjustments may be made in increments of 10 mg per day at intervals of at least one week, up to a maximum of 50 mg/day for immediate-release or 62.5 mg/day for controlled-release formulations. For panic disorder, initial dosing often begins at 10 mg to minimize initial agitation, with maintenance typically between 40–60 mg/day. Paroxetine should be taken with food to minimize gastrointestinal upset. Tablets must be swallowed whole; do not crush or chew controlled-release formulations.
Precautions
Patients should be monitored for clinical worsening, suicidality, or unusual changes in behavior, especially during the initial months of therapy or after dose changes. Paroxetine may cause activation or insomnia; consider morning administration. Use with caution in patients with a history of mania or bipolar disorder. Abrupt discontinuation may lead to withdrawal symptoms such as dizziness, sensory disturbances, agitation, or anxiety. A gradual taper is recommended under medical supervision. Paroxetine may impair judgment, thinking, or motor skills; advise patients to avoid driving or operating machinery until they know how the medication affects them.
Contraindications
Paroxetine is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to the risk of serotonin syndrome. Concomitant use with thioridazine or pimozide is contraindicated. It should not be used in patients with known hypersensitivity to paroxetine or any component of the formulation. Avoid use during pregnancy unless potential benefits justify potential risks to the fetus, particularly during the first trimester.
Possible side effect
Common side effects (≥1%) include nausea, somnolence, asthenia, dizziness, insomnia, sweating, sexual dysfunction, constipation, and decreased appetite. Less frequently, dry mouth, tremor, blurred vision, yawning, and weight changes may occur. Serious but rare adverse effects include serotonin syndrome, hyponatremia (especially in elderly patients), abnormal bleeding, angle-closure glaucoma, and seizures. Some patients may experience activation symptoms such as anxiety, agitation, or panic attacks early in treatment.
Drug interaction
Paroxetine is a strong inhibitor of CYP2D6 and may increase plasma concentrations of drugs metabolized by this enzyme, including tricyclic antidepressants, antipsychotics, beta-blockers, and certain antiarrhythmics. Concomitant use with other serotonergic drugs (e.g., tramadol, triptans, other SSRIs/SNRIs) increases the risk of serotonin syndrome. Avoid use with NSAIDs, aspirin, or warfarin due to increased bleeding risk. Paroxetine may reduce the efficacy of tamoxifen. Use caution with drugs that prolong QT interval.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the usual dosing schedule. Do not double the dose to make up for a missed one. Consistent daily administration is important to maintain stable serum levels.
Overdose
Symptoms of overdose may include nausea, vomiting, tremor, agitation, dizziness, tachycardia, dilated pupils, and somnolence. Severe overdose may lead to serotonin syndrome, seizures, coma, or ECG changes including QT prolongation. There is no specific antidote; treatment is supportive and symptomatic. Gastric lavage or activated charcoal may be considered if ingestion was recent. Ensure adequate airway and monitor cardiac and vital signs.
Storage
Store at room temperature (20–25°C or 68–77°F), in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual response to paroxetine may vary. Not all uses or risks are covered here.
Reviews
Clinical studies and meta-analyses consistently demonstrate paroxetine’s efficacy in reducing symptoms of depression and anxiety disorders. In head-to-head trials, it often shows comparable or superior effectiveness to other SSRIs for certain anxiety spectra. Patient-reported outcomes frequently cite improved mood, reduced anxiety, and better functional capacity, though side effects such as weight gain and sexual dysfunction are commonly noted. Long-term studies support its maintenance benefits in preventing relapse. Always discuss personal experiences and treatment goals with a prescribing clinician.